Skip to content

The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline

Published on:
Authors
W.H. van Brakel, P. G. Nicholls, L. Das, P. Barkataki, P. Maddali, D. Lockwood, E. Wilder-Smith

Leprosy is known for the neuropathy it causes. Different methods have been used to detect leprosy-related nerve function impairment (NFI).More sophisticated methods for assessing nerve function such as vibrometry, laser Doppler flowmetry and thermal threshold testing have been shown to detect different modalities of leprous neuropathy. However, it is not known which of these testing methods would detect the neuropathy earliest. To determine this, the methods needed to be compared in a carefully planned prospective study.

Related work

  • Long Term Collaboration with Netherlands Leprosy Relief

    • Institute
    • Project

    In a long-term collaboration, KIT Royal Tropical Institute and the Netherlands Leprosy Relief (NLR) have been working to reduce leprosy, whilst improving methods for its evaluation and study. This has resulted in significant research contribution and global policy setting, as well as country-level improvements in leprosy detection and control. Furthering the agenda in global leprosy […]

  • Genetic, household and spatial clustering of leprosy on an island in Indonesia: a population-based study

    • Institute
    • Publication

    It is generally accepted that genetic factors play a role in susceptibility to both leprosy per se and leprosy type, but only few studies have tempted to quantify this. Estimating the contribution of genetic factors to clustering of leprosy within families is difficult since these persons often share the same environment. The first aim of this study […]

  • Treatment with corticosteroids of long-standing nerve function impairment in leprosy: a randomized controlled trial (TRIPOD 3)

    • Institute
    • Publication

    Nerve Function Impairment (NFI) in leprosy patients may lead to severe disabilities, such as muscle paralysis of face, hands and feet, and chronic plantar and palmar ulceration. For many years, the mainstay of treatment of NFI of less than 6 months duration, in particular in the presence of clinically manifest type 1 reaction, has been […]